Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Black Widow Spider Bite : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Brown Recluse Spider Bite

Insect Bites




Patient Education
Bites and Stings Center

Black Widow Spider Bite Overview

Black Widow Spider Bite Symptoms

Black Widow Spider Bite Treatment




Author: Adam S Stibich, MD, Staff Physician, Department of Dermatology, University of Medicine and Dentistry of New Jersey

Adam S Stibich is a member of the following medical societies: American Academy of Dermatology and American Medical Association

Coauthor(s): Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School

Editors: James J Nordlund, MD, Professor Emeritus, Department of Dermatology, University of Cincinnati College of Medicine; David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic; Jeffrey J Miller, MD, Associate Professor, Department of Dermatology, Penn State University, Milton S Hershey Medical Center; Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System

Author and Editor Disclosure

Synonyms and related keywords: Latrodectus mactans bite, L mactans bite, hourglass spider bite, neurotoxin, latrotoxin, salivation, lacrimation, diaphoresis

Background

The black widow, or hourglass, spider is the most dangerous species in the United States because of its potent venom. Spiders of the genus Latrodectus are worldwide in distribution. In the United States, they are found in every state except Alaska. They are predominantly observed in southern and western states. Five species of widow spiders are extant in the United States.

Spiders of the Latrodectus genus are not aggressive, biting only when disturbed. Black widow spiders spin webs and await their prey. They can usually be found in their webs, which are often located near protected places, such as the undersides of stones and logs; in the angles of doors, windows, and shutters; and in littered areas such as city dumps, garages, barns, outhouses, and sheds. Often, these webs are found around outdoor toilet seats, resulting in bites on or near the genitalia.

Adult females are mostly jet-black and often have striking red markings on their abdomens. On the ventral surface of the globular abdomen is a characteristic marking that consists of 2 equilateral triangles arranged apex to apex in an hourglass configuration.

Pathophysiology

The venom of the black widow is a neurotoxin. It primarily causes systemic symptoms with little local damage at the bite site and no local necrosis. The venom mediates its effects through an initial release of massive amounts of acetylcholine at neuromuscular junctions. Latrotoxin is specific to nerve terminals; no direct release of transmitters from the adrenal medulla has been shown. As depolarization of the membrane occurs, a Ca++-dependent release of neurotransmitters down the concentration gradient ensues. Reuptake of the neurotransmitters appears to be blocked as well.

Frequency

United States

The incidence of envenomation from black widow spiders is unknown. In Texas, 760 black widow spider bites were documented from 1998-2002, with an increased prevalence in western Texas.

Mortality/Morbidity

More than 13,000 spider bites were reported to the American Association of Poison Control Centers in 1997, with no deaths; more than 1,300 of the bites were described as moderate or severe. The reported death rate from documented bites occurs in less than 1% of reported cases. Young children appear to be at highest risk for a lethal bite.

Age

Envenomation can occur in people of any age. The very young, the very old, and persons with cardiovascular disease are at increased risk for complications.



History

Envenomation can occur in people of any age. Initially, a severe pain in local muscle groups occurs, which then spreads to regional muscle groups. Severe cramps and contraction of musculature may extend throughout the body. The abdominal pains are frequently most severe, mimicking appendicitis, colic, or food poisoning. Other symptoms include headache, restlessness, anxiety, fatigue, and insomnia.

Physical

Signs of latrodectism include salivation, lacrimation, diaphoresis, tremors, tachycardia, bradycardia, hypertension, shock, and coma. Slight erythema, piloerection locally, mild edema or urtication, local perspiration, and lymphangiitis are the primary local features that may be present.



Brown Recluse Spider Bite
Insect Bites

Other Problems to be Considered

Acute abdomen (appendicitis, colic, food poisoning)
Acute fatal toxic myocarditis
Acute hypertension
Acute renal failure
Compartment syndrome
Drug withdrawal
Meningitis
Muscle cramping
Nonischemic priapism
Tetanus



Lab Studies

  • Laboratory evaluation is not helpful in diagnosis, although hemoglobinuria, albuminuria, and leukocytosis may be found.

Histologic Findings

Nonspecific bites mainly show neutrophils during the early toxic response and a mononuclear infiltrate of lymphoid cells and plasma cells during the later allergic response. Eosinophils are few to absent.



Medical Care

The outcome, even in untreated cases of black widow bites, generally is favorable with supportive care. Most patients do not require hospitalization, and symptoms subside in approximately 2 days; however, consider the very young and the very old, as well as patients with cardiovascular disease, at increased risk for complications.

Treatment centers on alleviating pain and muscle cramping. The 3 main treatments are pain relievers such as narcotics, muscle relaxants, and intravenous calcium gluconate. A spider antivenin produced in horses is available for Latrodectus venom and appears efficacious no matter which Latrodectus species bit the victim. Patients appropriately treated with antivenin recover rapidly in 1-2 days, but fatigue, weakness, and other nonspecific symptoms may persist for 7-10 days. Because the possibility of anaphylaxis or serum sickness always exists, use antivenin only in those who are at high risk for severe complications. Premedication with diphenhydramine, methylprednisolone, ranitidine, and acetaminophen may help to decrease the possible allergic reaction to antivenin infusion.



The 3 main treatments are pain relievers such as narcotics, muscle relaxants, and intravenous calcium gluconate. An antivenin produced in horses is available for Latrodectus venom and appears efficacious no matter which Latrodectus species bit the victim. Patients appropriately treated with antivenin recover rapidly in 1-2 days, but fatigue, weakness, and other nonspecific symptoms may persist for 7-10 days. Because the possibility of anaphylaxis or serum sickness always exists, use the antivenin only in those who are at high risk for severe complications. As with all spider bites, consider tetanus prophylaxis.

Drug Category: Electrolyte supplements

Agents such as calcium gluconate appear to reduce morbidity and complications.

Drug NameCalcium gluconate (Kalcinate)
DescriptionMechanism of action remains uncertain. Moderates nerve and muscle performance and facilitates normal cardiac function. Can be administered IV initially, and calcium levels maintained with high-calcium diet.
Adult Dose1-2 mL/kg of 10% solution as slow IV; not to exceed 10 mL/dose
Pediatric DoseAdminister as in adults
ContraindicationsRenal calculi; hypercalcemia; hypophosphatemia; renal or cardiac disease; digitalis toxicity
InteractionsMay decrease effects of tetracyclines, atenolol, salicylates, iron salts, and fluoroquinolones; antagonizes effects of verapamil; large intakes of dietary fiber may decrease calcium absorption and levels
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsExtravasation necrosis; caution in digitalized patients, respiratory failure, acidosis, or severe hyperphosphatemia

Drug Category: Narcotic analgesics

Relieve moderate to severe pain and decrease smooth muscle spasm.

Drug NameMeperidine (Demerol)
DescriptionAnalgesic with multiple actions similar to those of morphine; may produce less constipation, smooth muscle spasm, and depression of cough reflex than similar analgesic doses of morphine.
Adult Dose50-150 mg PO/IV q3-4h prn; adjust dose according to severity of pain and response of patient
Pediatric Dose0.5-0.8 mg/lb up to adult dose q3-4h prn
ContraindicationsDocumented hypersensitivity; administration of MAOIs; upper airway obstruction or significant respiratory depression; administration during labor when delivery of premature infant is anticipated
InteractionsMonitor for increased respiratory and CNS depression with coadministration of cimetidine; hydantoins may decrease effects of meperidine; avoid with protease inhibitors
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in patients with head injuries because meperidine may increase respiratory depression and CSF pressure (use only if absolutely necessary); caution when using postoperatively and with history of pulmonary disease (suppresses cough reflex); substantially increased dose levels, because of tolerance, may aggravate or cause seizures, even if no prior history of convulsive disorders; monitor closely for morphine-induced seizure activity if prior seizure history

Drug Category: Antivenins

Used to treat patients with symptoms due to bite by the black widow spider, L mactans.

Drug NameLatrodectus antivenin
DescriptionNeutralizes toxin, reducing morbidity and complications.
Adult Dose2.5 mL IM in anterolateral thigh; 2.5 mL of antivenin can be diluted in 10-50 mL of saline and administered IV over a 15-min period in severe cases or when patient is <12 y or in shock
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity (may administer in severe envenomation despite hypersensitivity)
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsBecause of the presence of horse serum, agents for emergency treatment of anaphylaxis should be available



Prognosis

Patient Education



Special Concerns

  • The antivenin is an equine serum derivative and poses a small risk of serum sickness and life-threatening anaphylaxis. Moreover, it may sensitize the blood, resulting in subsequent allergy that would prohibit future administration of any antivenin containing equine serum, such as snake antivenins.



Media file 1:  Black widow spider. Reprinted with permission from Cutis 1995; 56: 257.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Black widow spider (Latrodectus mactans) with egg sac. Photo by Sean Bush, MD.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Black widow spider (Latrodectus mactans) and offspring. Photo by Sean Bush, MD.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Carbonaro PA, Janniger CK, Schwartz RA. Spider bite reactions. Cutis. Nov 1995;56(5):256-9. [Medline].
  • Cohen J, Bush S. Case report: compartment syndrome after a suspected black widow spider bite. Ann Emerg Med. Apr 2005;45(4):414-6. [Medline].
  • Forrester MB, Stanley SK. Black widow spider and brown recluse spider bites in Texas from 1998 through 2002. Vet Hum Toxicol. Oct 2003;45(5):270-3. [Medline].
  • Hoover NG, Fortenberry JD. Use of antivenin to treat priapism after a black widow spider bite. Pediatrics. Jul 2004;114(1):e128-9. [Medline].
  • Karcioglu O, Gumustekin M, Tuncok Y, Celik A. Acute renal failure following latrodectism. Vet Hum Toxicol. Jun 2001;43(3):161-3. [Medline].
  • Kemp ED. Bites and stings of the arthropod kind. Treating reactions that can range from annoying to menacing. Postgrad Med. Jun 1998;103(6):88-90, 93-6, 102 passim. [Medline].
  • Koh WL. When to worry about spider bites. Inaccurate diagnosis can have serious, even fatal, consequences. Postgrad Med. Apr 1998;103(4):235-6, 243-4, 249-50. [Medline].
  • Litovitz TL, Klein-Schwartz W, Dyer KS, et al. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 1998;16(5):443-97. [Medline].
  • Maretic Z. Latrodectism: variations in clinical manifestations provoked by Latrodectus species of spiders. Toxicon. 1983;21(4):457-66. [Medline].
  • Maso MJ, Lin RY, Bagley MP, et al. Immunopathological changes after multiple spider bites. Contact Dermatitis. Aug 1987;17(2):65-8. [Medline].
  • Moss HS, Binder LS. A retrospective review of black widow spider envenomation. Ann Emerg Med. Feb 1987;16(2):188-92. [Medline].
  • O''Malley GF, Dart RC, Kuffner EF. Successful treatment of latrodectism with antivenin after 90 hours. N Engl J Med. Feb 25 1999;340(8):657. [Medline].
  • Pneumatikos IA, Galiatsou E, Goe D, et al. Acute fatal toxic myocarditis after black widow spider envenomation. Ann Emerg Med. Jan 2003;41(1):158. [Medline].
  • Rauber A. Black widow spider bites. J Toxicol Clin Toxicol. 1983-84;21(4-5):473-85. [Medline].
  • Stack LB. Images in clinical medicine. Latrodectus mactans. N Engl J Med. Jun 5 1997;336(23):1649. [Medline].
  • Steen CJ, Carbonaro PA, Schwartz RA. Arthropods in dermatology. J Am Acad Dermatol. Jun 2004;50(6):819-42, quiz 842-4. [Medline].
  • Wilson DC, King LE Jr. Spiders and spider bites. Dermatol Clin. Apr 1990;8(2):277-86. [Medline].
  • Wong RC, Hughes SE, Voorhees JJ. Spider bites. Arch Dermatol. Jan 1987;123(1):98-104. [Medline].

Black Widow Spider Bite excerpt

Article Last Updated: Jan 27, 2006